Prokarium Secures $10 Million Investment from Saudi, Swedish and Korean Investors for Clinical Development of … – Business Wire (press release)
Business Wire (press release) |
Prokarium Secures $10 Million Investment from Saudi, Swedish and Korean Investors for Clinical Development of …
Business Wire (press release) KEELE, England & RIYADH, Saudi Arabia & STOCKHOLM, Sweden & SEOUL, South Korea–(BUSINESS WIRE)–Prokarium, the UK-based synthetic biology company that has developed Vaxonella, an oral, thermostable vaccine delivery platform, today announced the … |
